Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Turn off Animations

Turn on Animations

News

Terumo Medical Care Solutions - Pharmaceutical Solutions Divisions is focused on reliably manufacturing and supplying high-quality technologies and services to drug product manufacturers and patients. Part of the global Terumo Group in Japan, we create solutions to meet the everyday issues facing medicine.

Access the latest news, events and Terumo Medical Care Solutions - Pharmaceutical Solutions Division's insights here

Access Here

Find Terumo news and press releases here:

Group and corporate news

Terumo Europe

Terumo Medical Corporation

Group and corporate news

Terumo Europe

Terumo Medical Corporation

For all press and media enquiries

If you are a journalist with a media enquiry, please contact:

Ireen Stanford - Global Marketing Communication Manager

+ 3216381283

Ireen.Stanford@terumo-europe.com

Please note that this route is intended for journalists with specific media enquiries. For any non-media enquiries please visit our

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.